Learn / MYGN
NASDAQ: MYGN
Myriad Genetics (MYGN) stock, explained like you're 5
Myriad Genetics trades on the Nasdaq under the ticker MYGN. It is a small cap company in the in vitro & in vivo diagnostic substances industry, part of the healthcare sector, with a market value of about 412 million dollars.
- Ticker
- MYGN
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- In Vitro & In Vivo Diagnostic Substances
- Size
- Small cap, about 412 million dollars
Is Myriad Genetics a small, medium or large cap company?
No. Myriad Genetics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 412 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Myriad Genetics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves MYGN stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Myriad Genetics, Inc. (MYGN) Stock Price, News, Quote & History (Yahoo! Finance Canada)
- Myriad Genetics, Inc. (MYGN) stock price, news, quote and history (Yahoo Finance UK)
- What Myriad Genetics Doubters Saw Before The Drop (Simply Wall Street)
- MYGN Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Myriad Genetics (MYGN) (Business Wire)
- Myriad Genetics stock fell 8.51 percent to USD 3.98 on October 16, 2026 (ad-hoc-news.de)
Follow MYGN in your daily brief
Each trading day at 5 PM ET we post what happened to Myriad Genetics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow MYGN
Questions about Myriad Genetics stock
What does Myriad Genetics do?
Myriad Genetics trades on the Nasdaq under the ticker MYGN. It is a small cap company in the in vitro & in vivo diagnostic substances industry, part of the healthcare sector, with a market value of about 412 million dollars.
What is the ticker symbol for Myriad Genetics?
Myriad Genetics trades under the ticker MYGN on the Nasdaq.
What is Myriad Genetics's market cap?
Myriad Genetics is a small cap stock with a market cap of about 412 million dollars.
How does Myriad Genetics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves MYGN stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow MYGN stock every day?
Add MYGN to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.